Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research

Murine erythroleukemia (MEL) cells are often employed as a model to dissect mechanisms of erythropoiesis and erythroleukemia in vitro. Here, an allograft model using MEL cells resulting in splenomegaly was established to develop a diagnostic model for isolation/quantification of metastatic cells, an...

Full description

Bibliographic Details
Main Authors: Min Young Kim, Sungwoo Choi, Seol Eui Lee, Ji Sook Kim, Seung Han Son, Young Soo Lim, Bang-Jin Kim, Buom-Yong Ryu, Vladimir N. Uversky, Young Jin Lee, Chul Geun Kim
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/11/1707
_version_ 1797707419763081216
author Min Young Kim
Sungwoo Choi
Seol Eui Lee
Ji Sook Kim
Seung Han Son
Young Soo Lim
Bang-Jin Kim
Buom-Yong Ryu
Vladimir N. Uversky
Young Jin Lee
Chul Geun Kim
author_facet Min Young Kim
Sungwoo Choi
Seol Eui Lee
Ji Sook Kim
Seung Han Son
Young Soo Lim
Bang-Jin Kim
Buom-Yong Ryu
Vladimir N. Uversky
Young Jin Lee
Chul Geun Kim
author_sort Min Young Kim
collection DOAJ
description Murine erythroleukemia (MEL) cells are often employed as a model to dissect mechanisms of erythropoiesis and erythroleukemia in vitro. Here, an allograft model using MEL cells resulting in splenomegaly was established to develop a diagnostic model for isolation/quantification of metastatic cells, anti-cancer drug screening, and evaluation of the tumorigenic or metastatic potentials of molecules in vivo. In this animal model, circulating MEL cells from the blood stream were successfully isolated and quantified with an additional in vitro cultivation step. In terms of the molecular-pathological analysis, we were able to successfully evaluate the functional discrimination between methyl-CpG-binding domain 2 (Mbd2) and p66α in erythroid differentiation, and tumorigenic potential in spleen and blood stream of allograft model mice. In addition, we found that the number of circulating MEL cells in anti-cancer drug-treated mice was dose-dependently decreased. Our data demonstrate that the newly established allograft model is useful to dissect erythroleukemia pathologies and non-invasively provides valuable means for isolation of metastatic cells, screening of anti-cancer drugs, and evaluation of the tumorigenic potentials.
first_indexed 2024-03-12T06:07:06Z
format Article
id doaj.art-d02524d566254c02b531d233aca90799
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:07:06Z
publishDate 2019-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d02524d566254c02b531d233aca907992023-09-03T03:35:35ZengMDPI AGCancers2072-66942019-11-011111170710.3390/cancers11111707cancers11111707Development of a MEL Cell-Derived Allograft Mouse Model for Cancer ResearchMin Young Kim0Sungwoo Choi1Seol Eui Lee2Ji Sook Kim3Seung Han Son4Young Soo Lim5Bang-Jin Kim6Buom-Yong Ryu7Vladimir N. Uversky8Young Jin Lee9Chul Geun Kim10Department of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaDepartment of Animal Science & Technology, Chung-Ang University, Ansung, Gyeonggi-do 17546, KoreaDepartment of Animal Science & Technology, Chung-Ang University, Ansung, Gyeonggi-do 17546, KoreaDepartment of Molecular Medicine, USF Health Byrd Alzheimer’s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USAInstitute of Pharmaceutical Science and Technology, Department of Pharmacy, Hanyang University, Ansan, Gyeonggi-do 15588, KoreaDepartment of Life Science, College of Natural Sciences, Hanyang University, Seoul 04763, KoreaMurine erythroleukemia (MEL) cells are often employed as a model to dissect mechanisms of erythropoiesis and erythroleukemia in vitro. Here, an allograft model using MEL cells resulting in splenomegaly was established to develop a diagnostic model for isolation/quantification of metastatic cells, anti-cancer drug screening, and evaluation of the tumorigenic or metastatic potentials of molecules in vivo. In this animal model, circulating MEL cells from the blood stream were successfully isolated and quantified with an additional in vitro cultivation step. In terms of the molecular-pathological analysis, we were able to successfully evaluate the functional discrimination between methyl-CpG-binding domain 2 (Mbd2) and p66α in erythroid differentiation, and tumorigenic potential in spleen and blood stream of allograft model mice. In addition, we found that the number of circulating MEL cells in anti-cancer drug-treated mice was dose-dependently decreased. Our data demonstrate that the newly established allograft model is useful to dissect erythroleukemia pathologies and non-invasively provides valuable means for isolation of metastatic cells, screening of anti-cancer drugs, and evaluation of the tumorigenic potentials.https://www.mdpi.com/2072-6694/11/11/1707circulating tumor cellserythroleukemiaallograftliquid biopsycancer treatment
spellingShingle Min Young Kim
Sungwoo Choi
Seol Eui Lee
Ji Sook Kim
Seung Han Son
Young Soo Lim
Bang-Jin Kim
Buom-Yong Ryu
Vladimir N. Uversky
Young Jin Lee
Chul Geun Kim
Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
Cancers
circulating tumor cells
erythroleukemia
allograft
liquid biopsy
cancer treatment
title Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
title_full Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
title_fullStr Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
title_full_unstemmed Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
title_short Development of a MEL Cell-Derived Allograft Mouse Model for Cancer Research
title_sort development of a mel cell derived allograft mouse model for cancer research
topic circulating tumor cells
erythroleukemia
allograft
liquid biopsy
cancer treatment
url https://www.mdpi.com/2072-6694/11/11/1707
work_keys_str_mv AT minyoungkim developmentofamelcellderivedallograftmousemodelforcancerresearch
AT sungwoochoi developmentofamelcellderivedallograftmousemodelforcancerresearch
AT seoleuilee developmentofamelcellderivedallograftmousemodelforcancerresearch
AT jisookkim developmentofamelcellderivedallograftmousemodelforcancerresearch
AT seunghanson developmentofamelcellderivedallograftmousemodelforcancerresearch
AT youngsoolim developmentofamelcellderivedallograftmousemodelforcancerresearch
AT bangjinkim developmentofamelcellderivedallograftmousemodelforcancerresearch
AT buomyongryu developmentofamelcellderivedallograftmousemodelforcancerresearch
AT vladimirnuversky developmentofamelcellderivedallograftmousemodelforcancerresearch
AT youngjinlee developmentofamelcellderivedallograftmousemodelforcancerresearch
AT chulgeunkim developmentofamelcellderivedallograftmousemodelforcancerresearch